Wells Fargo initiated coverage on Align Tech with a new price target
$ALGN
Industrial Specialties
Health Care
Wells Fargo initiated coverage of Align Tech with a rating of Overweight and set a new price target of $255.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/14/2025 | $255.00 | Overweight | Wells Fargo |
| 1/6/2025 | $235.00 → $280.00 | Market Perform → Outperform | Leerink Partners |
| 12/4/2024 | $295.00 | Outperform | Mizuho |
| 10/10/2024 | Hold | Needham | |
| 2/26/2024 | $310.00 | Market Perform | Leerink Partners |
| 12/11/2023 | $197.00 | Neutral → Sell | Goldman |
| 10/27/2023 | $200.00 | Buy → Neutral | UBS |
| 2/2/2023 | $165.00 → $307.00 | Sell → Neutral | Goldman |
8-K - ALIGN TECHNOLOGY INC (0001097149) (Filer)
10-Q - ALIGN TECHNOLOGY INC (0001097149) (Filer)
8-K - ALIGN TECHNOLOGY INC (0001097149) (Filer)
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
Invisalign® Palatal Expanders offer doctors a removeable, safe, and clinically effective alternative to traditional palatal expanders. With Invisalign First™ aligners and Invisalign® Palatal Expanders, Align Technology now provides doctors with a full early intervention treatment solution, including both skeletal (orthopedic) and dental (orthodontic) arch expansion. Align Technology, Inc. ("Align") (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Align's Invisalign Palatal
Q4 total revenues of $995.2 million and FY2024 total revenues of $4.0 billion Q4 and FY2024 total revenues up 4.0% year-over-year and up 3.5% year-over-year, respectively Q4 Clear Aligner volumes up 1.9% sequentially, and up 6.1% year-over-year Q4 Systems and Services revenues up 5.2% sequentially, and up 14.9% year-over-year 2024 total revenues of $4.0 billion, Clear Aligner revenues of $3.2 billion and Systems and Services revenues of $768.9 million 2024 revenues were unfavorably impacted by foreign exchange of approximately $38.5 million compared to 2023(1) 2024 operating margin of 15.2%, non-GAAP operating margin of 21.8%, and diluted net income per share of $5.62, non-GA
Patrick Mahomes, Kansas City Chief's quarterback, to share his personal Invisalign® treatment experience with fans Align Technology, Inc. ("Align") (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Patrick Mahomes, quarterback for the National Football League's (NFL) Kansas City Chiefs, has joined the Invisalign Smile Squad as an ambassador for the brand. As part of the multi-year agreement, Patrick will share his Invisalign treatment experience with fans in a multi-channel cam
Q4 total revenues of $995.2 million and FY2024 total revenues of $4.0 billion Q4 and FY2024 total revenues up 4.0% year-over-year and up 3.5% year-over-year, respectively Q4 Clear Aligner volumes up 1.9% sequentially, and up 6.1% year-over-year Q4 Systems and Services revenues up 5.2% sequentially, and up 14.9% year-over-year 2024 total revenues of $4.0 billion, Clear Aligner revenues of $3.2 billion and Systems and Services revenues of $768.9 million 2024 revenues were unfavorably impacted by foreign exchange of approximately $38.5 million compared to 2023(1) 2024 operating margin of 15.2%, non-GAAP operating margin of 21.8%, and diluted net income per share of $5.62, non-GA
Align Technology, Inc. (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report fourth quarter and 2024 financial results on Wednesday, February 5, 2025, after the close of market. Financial results will be released at 4:00 p.m. ET (2:00 p.m. MT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call w
Company expects to repurchase up to $275.0 million of its common stock beginning in Q4'24 Q3'24 total revenues of $977.9 million, increased 1.8% year-over-year, and Q3'24 diluted net income per share was $1.55, or $2.35 on a non-GAAP diluted basis Q3'24 total revenues were unfavorably impacted by foreign exchange by approximately $14.6 million year-over-year(1), and were not significantly impacted sequentially Q3'24 operating income of $162.3 million and operating margin of 16.6%, non-GAAP operating margin of 22.1% Q3'24 GAAP operating margin was unfavorably impacted by foreign exchange by approximately 0.8 points year-over-year(1), and was not significantly impacted sequentially
Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced it has appointed Emory Wright, executive vice president, direct fabrication manufacturing platform, effective immediately. Mr. Wright will transition his current responsibilities for global operations, including treatment planning, and focus on scaling Align's next generation direct fabrication manufacturing platform, working in close collaboration with Srini Kaza, who was promoted to executive vice president, res
Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that after nearly six years with Align, Yuval Shaked, executive vice president and managing director of iTero scanner and services, has decided to leave the company for personal reasons and spend more time with his family. He will remain with Align and continue as a member of Align Technology President and CEO Joe Hogan's staff supporting strategic initiatives and programs through 2023. Mr. Shaked will transition
TEMPE, Ariz., SAN JOSE, Calif., and SINGAPORE, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Raj Pudipeddi, Align Technology chief product and marketing officer, and senior vice president will assume additional responsibility for the commercial organization in the Asia Pacific region as managing director, effective immediately, succeeding Julie Tay, Align Technology senior vice president and managing director, Asia Pacifi
SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)
SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)
SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)
Wells Fargo initiated coverage of Align Tech with a rating of Overweight and set a new price target of $255.00
Leerink Partners upgraded Align Tech from Market Perform to Outperform and set a new price target of $280.00 from $235.00 previously
Mizuho initiated coverage of Align Tech with a rating of Outperform and set a new price target of $295.00